Longeveron Inc. (LGVN) Dividend History

Company News

• Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting

  Longeveron presented positive long-term survival data for its Lomecel-B treatment in patients with Hypoplastic Left Heart Syndrome (HLHS). The data showed 100% 5-year survival and transplant-free rates, outperforming historical data. The findings support the potential of Lomecel-B as an adjunct therapy to improve outcomes for HLHS patients.

  GlobeNewswire Inc.
• Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga

  WD-40 Company reported stronger-than-expected Q3 results, leading to a 12.5% jump in its stock price in pre-market trading. Several other stocks also saw significant price movements in the pre-market session.

  Benzinga

  Featured Companies: ASNS CING CTM IVP LUCY LVWR NEGG PSMT SPRC WDFC YGMZ
• Should New Investors Buy Penny Stocks?

  Why New Investors Should Look Into Investing in Penny Stocks Penny stocks… The post Should New Investors Buy Penny Stocks? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: BRTX STSS
• Longeveron stock jumps on Alzheimer's trial results

  Treatment derived from bone marrow shows promise in patients with mild Alzheimer's disease.

  MarketWatch
• 10 Best Performing Small-Cap Stocks In March 2022

  Investing.com

  Featured Companies: CENN FULC NEXT OWLT TH